Home » Topics » Disease categories and therapies » Musculoskeletal

Musculoskeletal
RSS

Biological synovectomy using Granzyme B gene therapy

June 12, 2001

LJP expands phase III lupus trial to Europe

June 12, 2001

FDA grants Protein Therapeutics' immunoglobulin orphan drug status for treatment of JRA

June 11, 2001

Novel TNF-alpha inhibitors and potential therapeutic uses reported by Sanofi-Synthelabo

June 7, 2001

Selective inhibitors of p38 kinase useful in inflammatory conditions

June 7, 2001

P&G patents new series of matrix metalloproteinase inhibitors and their use

June 1, 2001

Rofecoxib and celecoxib safe for use in aspirin-sensitive asthmatics

June 1, 2001

Recent patent covers new MMP inhibitors developed at Sankyo

May 31, 2001

Welfide describes new research in the area of cytokine modulation

May 30, 2001

Inhibitors of IL-6 production particularly useful in inflammatory diseases

May 29, 2001

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 11, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...
Wuxi Apptec insists it’s ‘not a Chinese military company’
BioWorld
Wuxi Apptec isn’t going down without a fight after the U.S. Department of Defense added it to the Section 1260H list June 8 as a designated “Chinese military...
Parabilis takes top spot, pricing largest biopharma IPO at $670M
BioWorld
Less than two months after Kailera Therapeutics Inc. made headlines with biopharma’s largest IPO to date, Parabilis Medicines Inc. has come along and surpassed...